Fundz

Isracann Biosciences reported raising $3,740 in an initial SEC Form D filing, from an offering of $7,780

PRIVATENov 14, 2022$3.7K of $7.8K raised

Amount Raised

$3,740

$3,740 sold, per SEC Form D (first sale Nov 4, 2022)

Round Type

Seed

Information TechnologyHardwareCommunity And LifestyleHealth CareAgriculture And FarmingFood And Beverage

Who else raised in Hardware and Community And Lifestyle around the same time

Companies in the same sectors as Isracann Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • PetPlate, Inc. raised $5M on October 14, 2022.
  • COVETRUS, INC. raised $120M on December 5, 2022.
  • Trait Biosciences Inc. raised $230K (Series A) on November 16, 2022.
  • Local Bounti raised $15M on October 21, 2022.
  • Variantyx raised $20M on October 18, 2022.
  • INDYA raised an undisclosed amount (Funding Round) on October 14, 2022.

Who to call at Isracann Biosciences, and when

A new round usually means Isracann Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Isracann Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Isracann Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Isracann Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Isracann Biosciences

Location

1600 - 595 BURRARD STREET

About

Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann has a joint venture agreement in place with a built 55,000 sqft farm, which is expandable to 160,000 sq ft in the near term and has access to over 2,000,000 sq ft of private land. The company is targeting undersupplied domestic demand combined with an immense international market opportunity through Israel’s new medical cannabis export framework for 2020.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Isracann Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Isracann Biosciences's next move

See what Strategic adds

Isracann Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.